News Archive

Read more about the new hope found in Phase 1 clinical trials for the HIV vaccine.

Here is more information about the NIH trials and what Dr. Diemert and other infectious disease experts have to say about the progress in the monkeypox vaccine.

Check out this interview with our very own Dr. Diemert, the director of the GW Vaccine Research Unit on WTOP to learn more about our current monkeypox trial.

NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply.

Dr. Diemert and other infectious disease experts discuss the search for a universal COVID-19 vaccine and comparisons to the seasonal influenza vaccine.

Doreen Gentzler, NBC4 News Anchor, interviews GW VRU Director, Dr. David Diemert on monkeypox myths and facts.

Long-awaited protection for tots appears close to arrival. Moderna also get clearance for vaccine for 6- to 17-year olds.

How is the shot different from Pfizer, Moderna and J&J? Does it work against new variants? Here's what to know.

Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the…

The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron.